Patent foramen ovale and migraine

Del Sette M, Angeli S, Leandri M, et al.: Migraine with aura and right-to-left shunt on transcranial Doppler: a casecontrol study. Cerebrovasc Dis 1998, 8:327–330.

Anzola GP, Magoni M, Guindani M, et al.: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999, 52:1622–1625.

Dalla Volta G, Guindani M, Zavarise P, et al.: Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005, 6:328–330.

Schwerzmann M, Nedeltchev K, Lagger F, et al.: Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005, 65:1415–1418.

Carod-Artal FJ, da Silveira Ribeiro L, Braga H, et al.: Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 2006, 26:934–939.

Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, et al.: Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006, 67:1128–1134.

Schwedt TJ, Dodick DW: Patent foramen ovale and migraine—bringing closure to the subject. Headache 2006, 46:663–671.

Bousser MG: Patent foramen ovale and migraine: evidence for a link? Headache Currents 2006, 3:44–51.

Wilmshurst PT, Pearson MJ, Nightingale S, et al.: Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004, 90:1315–1320.

Moussouttas M, Fayad P, Rosenblatt M, et al.: Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000, 55:959–964.

White RI Jr, Lynch-Nyhan A, Terry P, et al.: Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988, 169:663–669.

Mortelmans K, Post M, Thijs V, et al.: The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 2005, 26:1533–1537.

Sztajzel R, Genoud D, Roth S, et al.: Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002, 13:102–106.

Lamy C, Giannesini C, Zuber M, et al.: Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002, 33:706–711.

Venketasubramanian N, Sacco RL, Di Tullio M, et al.: Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology 1993, 43:1533–1535.

Crassard I, Conard J, Bousser MG: Migraine and haemostasis. Cephalalgia 2001, 21:630–636.

Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005, 91:1173–1175.

Riederer F, Kaya M, Christina P, et al.: Migraine with aura related to closure of atrial septal defects. Headache 2005, 45:953–956.

Steele JG, Nath PU, Burn J, Porteous ME: An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache 1993, 33:145–148.

Dowson AJ, Wilmshurst P, Muir KW, et al.: A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFlex septal repair implant to prevent refractory migraine headaches: the MIST trial. Neurology 2006, 67:185.

Lampl C, Bonelli S, Ransmayr G: Efficacy of topiramate in migraine aura prophylaxis: preliminary results of 12 patients. Headache 2004, 44:174–177.

Lampl C, Katsarava Z, Diener HC, Limmroth V: Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 2005, 76:1730–1732.

Schwerzmann M, Wiher S, Nedeltchev K, et al.: Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004, 62:1399–1401.

Post M, Thijs V, Herroelen L, Budts W: Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004, 62:1439–1440.

Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000, 356:1648–1651.

Reisman M, Christofferson RD, Jesurum J, et al.: Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005, 45:493–495.

Azarbal B, Tobis J, Suh W, et al.: Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005, 45:489–492.

Buring JE, Peto R, Hennekens CH: Low-dose aspirin for migraine prophylaxis. JAMA 1990, 264:1711–1713.

Diener HC, Hartung E, Chrubasik J, et al.: A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001, 21:120–128.

Bensenor IM, Cook NR, Lee IM, et al.: Low-dose aspirin for migraine prophylaxis in women. Cephalalgia 2001, 21:175–183.

Sharifi M, Burks J: Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv 2004, 63:255.

Lapergue B, Rosso C, Hadrane L, et al.: Frequency of migraine attacks following stroke starts to decrease before PFO closure. Neurology 2006, 67:1099–1100.

Wilmshurst P, Nightingale S: Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001, 100:215–220.

Morandi E, Anzola GP, Angeli S, et al.: Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003, 16:39–42.

Giardini A, Donti A, Formigari R, et al.: Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 2006, 67:625–629.